Need professional-grade analysis? Visit stockanalysis.com
$137.39M
N/A
N/A
N/A
Nyxoah (NYXH) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $3.26, down 0.61% from the previous close.
Over the past year, NYXH has traded between a low of $2.82 and a high of $8.32. The stock has lost 46.1% over this period. It is currently 60.8% below its 52-week high.
Nyxoah has a market capitalization of $137.39M.
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Side-by-side comparison against top Healthcare peers.